COVID-19 convalescent plasma boosts early antibody titer and does not influence the adaptive immune response
Author:
Publisher
American Society for Clinical Investigation
Subject
General Medicine
Link
https://insight.jci.org/articles/view/167890/files/pdf
Reference35 articles.
1. Monoclonal antibody therapies against SARS-CoV-2;Focosi;Lancet Infect Dis,2022
2. Genomic surveillance, evolution and global transmission of SARS-CoV-2 during 2019–2022
3. An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
4. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
5. Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial);Agarwal;BMJ,2020
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Safety of COVID‐19 convalescent plasma: A definitive systematic review and meta‐analysis of randomized controlled trials;Transfusion;2023-12-29
2. Clinical outcomes in hospitalized plasma and platelet transfusion recipients prior to and following widespread blood donor SARS‐CoV‐2 infection and vaccination;Transfusion;2023-12-06
3. Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy;Expert Review of Respiratory Medicine;2023-05-02
4. Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial;2023-04-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3